1. Home
  2. FUSE vs PDSB Comparison

FUSE vs PDSB Comparison

Compare FUSE & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUSE

Fusemachines Inc.

N/A

Current Price

$1.82

Market Cap

26.0M

Sector

Technology

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.08

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSE
PDSB
Founded
2013
2005
Country
United States
United States
Employees
270
10
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
29.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FUSE
PDSB
Price
$1.82
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
6.3M
841.4K
Earning Date
06-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.51
52 Week High
$3.67
$1.90

Technical Indicators

Market Signals
Indicator
FUSE
PDSB
Relative Strength Index (RSI) 67.21 74.98
Support Level $1.41 $1.02
Resistance Level $1.99 $1.12
Average True Range (ATR) 0.23 0.11
MACD 0.11 0.06
Stochastic Oscillator 70.55 90.37

Price Performance

Historical Comparison
FUSE
PDSB

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: